Yatırımcı.AI

ECILC vs PGSUS Comparison

Price, market cap, valuation, profitability and leverage metrics of ECILC and PGSUS side by side.

ECILCPGSUS
StockFund

If You Had Invested TRY 10,000

Metric Comparison

ECILC vs PGSUS Comparison
MetricECILCPGSUSSector median
Last price (TL)63.55142.3018.72
Daily change−7.23%−3.00%−6.42%
Market capTRY 43.5BTRY 71.2BTRY 4.3B
P/B0.680.651.09
Dividend yield2.04%—0.90%
Return on equity−3.08%−1.15%1.78%
Free float22.02%46.26%37.21%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the ECILC vs PGSUS Comparison

Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and PGSUS (Pegasus) side by side as of Sep 28, 2026, 14:25. Of the 15 metrics compared, ECILC leads in 6 and PGSUS leads in 9.

Highlights: Daily change: PGSUS leads (−3.00% vs −7.23%). Market cap: PGSUS leads (TRY 71.2B vs TRY 43.5B). P/B: PGSUS leads (0.65 vs 0.68). EV/EBITDA: PGSUS leads (8.76 vs 165.19). EV/Sales: PGSUS leads (3.29 vs 9.35). Gross margin: ECILC leads (37.83% vs −2.82%). EBITDA margin (annual): PGSUS leads (18.32% vs 11.49%). Net margin (annual): PGSUS leads (−0.76% vs −20.86%).

Frequently Asked Questions

By P/E, Tie is cheaper (— vs —); by P/B, PGSUS trades at the lower multiple (0.68 vs 0.65).

Annual net margin is −20.86% for ECILC and −0.76% for PGSUS; return on equity is −3.08% for ECILC and −1.15% for PGSUS.

The leverage ratio is 18.92 for ECILC and 74.42 for PGSUS; net debt/EBITDA is 1.37 for ECILC and 5.92 for PGSUS. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.